# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Primary progressive aphasia

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 11-20 of 74 results.
Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects
Status: Recruiting
Last Changed: Apr 03, 2020
First Received: Feb 26, 2015
Disease(s): Familial Frontotemporal Dementia
Locations: University of California, San Francisco, Memory and Aging Center, Department of Neurology, San Francisco, California, United States
Mayo Clinic Florida, Jacksonville, Florida, United States
Harvard University, Charlestown, Massachusetts, United States
Mayo Clinic, Rochester, Minnesota, United States
Washington University, Saint Louis, Missouri, United States
... and 4 other locations.
PPA Tele-Savvy: A Pilot Study of an Online Intervention for Caregivers of Persons Living With PPA
Status: Not yet recruiting
Last Changed: Jun 09, 2020
First Received: Jun 02, 2020
Disease(s): Primary Progressive Aphasia, Caregiver Burnout
Intervention(s): PPA Tele-Savvy Pilot Intervention
Locations: Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University, Chicago, Illinois, United States
A Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia
Status: Not yet recruiting
Last Changed: May 06, 2020
First Received: May 05, 2020
Disease(s): Frontotemporal Dementia
Intervention(s): AL001, Placebo
Can Magnetic Brain Stimulation Improve Language Function in Primary Progressive Aphasia
Status: Not yet recruiting
Last Changed: Dec 10, 2019
First Received: Dec 10, 2019
Disease(s): Logopenic Progressive Aphasia
Intervention(s): MagStim Rapid2 Transcranial Magnetic Simulation
Intranasal Insulin in Frontotemporal Dementia (FTD)
Status: Recruiting
Last Changed: Mar 11, 2020
First Received: Oct 04, 2019
Disease(s): Frontotemporal Dementia, Behavioral Variant
Intervention(s): Novolin-R insulin
Locations: HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States
Evaluation of a Transcranial Stimulation With Direct Current on Language Disorders in Semantic Dementia
Status: Recruiting
Last Changed: Feb 05, 2020
First Received: Mar 29, 2018
Disease(s): Semantic Dementia
Intervention(s): Transcranial stimulation
Locations: Département de Neurologie - Centre des maladies neurologiques, cognitives et comportementales, Paris, France
Hôpital de la Pitié-Salpétrière, Paris, France
Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal Dementia
Status: Recruiting
Last Changed: Aug 19, 2019
First Received: Aug 10, 2016
Disease(s): Frontotemporal Dementia (FTD)
Intervention(s): Lithium Carbonate, Placebo
Locations: Columbia University Medical Center, New York, New York, United States
Open‐Label Study of Long‐Term Safety and Efficacy of Intravenous Trappsol Cyclo (HPβCD) in Niemann‐Pick Disease Type C
Status: Recruiting
Last Changed: Mar 28, 2019
First Received: Mar 28, 2019
Disease(s): Niemann-Pick Disease, Type C1
Intervention(s): Hydroxypropyl-β-cyclodextrin
Locations: UCSF Benioff Children's Hospital Oakland, Oakland, California, United States
Combined Intrathecal and Intravenous VTS-270 Therapy for Liver and Neurological Disease Associated With Niemann-Pick Disease, Type C1
Status: Recruiting
Last Changed: Jan 31, 2020
First Received: Mar 25, 2019
Disease(s): Niemann-Pick Disease, Type C1
Intervention(s): VTS-270
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
A First in Human Study in Healthy Volunteers and in Participants With Frontotemporal Dementia With Granulin Mutation
Status: Recruiting
Last Changed: Apr 19, 2019
First Received: Aug 17, 2018
Disease(s): Healthy, Frontotemporal Dementia
Intervention(s): AL001, Placebo
Locations: University of Alabama, Birmingham, Alabama, United States
UCSF, San Francisco, California, United States
Study site, Orlando, Florida, United States
Mayo Clinic, Rochester, Minnesota, United States
University of Pennsylvania, Philadelphia, Pennsylvania, United States
... and 4 other locations.